Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. PRIM
3. MU
4. DPZ
5. ACN
6. NAVN
7. DFTX
8. IBM
9. META
10. ENRD

Go back to Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

Trevi Therapeutics (TRVI) Tops Q3 EPS by 2c

November 13, 2025 4:12 PM EST

Trevi Therapeutics (NASDAQ: TRVI) reported Q3 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.

... More